The Journal of Organic Chemistry
Article
Methyl-2-(8-cyano-5-(4-methoxyphenyl)-3-oxo-5H-thiazolo[3,2-
a]pyridin-2(3H)-ylidene)acetate (8b): Prepared according to GP-B;
after column chromatography (methylene chloride), an orange powder
Na]+ calcd for C19H16N2O4SNa 391.0723; found 391.0726; [M + K]+
calcd for C19H16N2O4SK 407.0462; found 407.0460.
Ethyl-2-(8-cyano-5-(4-(dimethylamino)phenyl)-3-oxo-5H-
thiazolo[3,2-a]pyridin-2(3H)-ylidene)acetate (8g): Prepared accord-
ing to GP-B; after column chromatography (methylene chloride), an
orange powder (0.114 mg, 30% yield) was obtained; mp = 181−183
°C; 1H NMR (DMSO-d6, 400 MHz) δ 7.14 and 6.67 (AA′XX′, 4H, J =
8.7 Hz), 6.72 (s, 1H), 6.23 (d, 1H, J = 9.7 Hz), 5.88 (d, 1H, J = 5.0 Hz),
5.84 (dd, 1H, J = 9.6 Hz, J = 4.7 Hz), 4.26 (q, 2H, J = 7.0 Hz), 2.87 (s,
6H), 1.26 (t, 3H, J = 7.1 Hz); 13C{1H} NMR (DMSO-d6, 100 MHz) δ
165.5, 163.1, 150.6, 146.8, 138.3, 128.0, 125.9, 123.4, 116.2, 115.9,
115.6, 112.3, 99.5, 84.3, 61.7, 57.7, 13.9; FT-IR (neat) νmax (cm−1)
3183, 3151, 3081, 3067, 3054, 3037, 2984, 2955, 2904, 2864, 2803,
2215, 1706, 1687; HRMS (ESI-TOF) m/z [M + H]+ calcd for
C20H19N3O3SH 382.1220; found 382.1232; [M + Na]+ calcd for
C20H19N3O3SNa 404.1039; found 404.1038; [M + K]+ calcd for
C20H19N3O3SK 420.0779; found 420.0775.
1
(0.234 mg, 66% yield) was obtained; mp = 169−171 °C; H NMR
(DMSO-d6, 400 MHz) δ 7.28 and 6.92 (AA′XX′, 4H, J = 8.5 Hz), 6.76
(s, 1H), 6.24 (d, 1H, J = 9.8 Hz), 5.97 (d, 1H, J = 4.0 Hz), 5.86 (dd, 1H,
J = 9.8, 4.6 Hz), 3.80 (s, 3H), 3.74 (s, 3H); 13C{1H} NMR (DMSO-d6,
100 MHz) δ 165.8, 162.8, 159.3, 146.7, 138.1, 130.7, 128.2, 122.9,
116.1, 115.7, 115.1, 114.1, 84.0, 57.3, 54.9, 52.4; FT-IR (neat) νmax
(cm−1) 3070, 3043, 3014, 2960, 2839, 2218, 1713, 1683; HRMS (ESI-
TOF) m/z [M + H]+ calcd for C18H14N2O4SH 355.0747; found
355.0744; [M + Na]+ calcd for C18H14N2O4SNa 377.0566; found
377.0570; [M + K]+ calcd for C18H14N2O4SK 393.0306; found
393.0301.
Methyl-2-(8-cyano-5-(4-(dimethylamino)phenyl)-3-oxo-5H-
thiazolo[3,2-a]pyridin-2(3H)-ylidene)acetate (8c): Prepared accord-
ing to GP-B; after column chromatography (methylene chloride), an
orange powder (0.184 mg, 50% yield) was obtained; mp = 210−212
°C; 1H NMR (DMSO-d6, 400 MHz) δ 7.14 and 6.67 (AA′XX′, 4H, J =
7.6 Hz), 6.75 (s, 1H), 6.23 (d, 1H, J = 9.6 Hz), 5.88 (d, 1H, J = 4.1 Hz),
5.84 (dd, 1H, J = 9.6 Hz, J = 4.0 Hz), 3.80 (s, 3H), 2.88 (s, 6H);
13C{1H} NMR (DMSO-d6, 100 MHz) δ 165.7, 162.8, 150.3, 146.5,
138.2, 127.8, 125.6, 123.1, 115.9, 115.7, 114.9, 112.0, 84.0, 57.5, 52.4,
39.6; FT-IR (neat) νmax (cm−1) 3066, 2954, 2888, 2803, 2217, 1707;
HRMS (ESI-TOF) m/z [M + H]+ calcd for C19H17N3O3SH 368.1063;
found 368.1069; [M + Na]+ calcd for C19H17N3O3SNa 390.0883;
found 390.0874; [M + K]+ calcd for C19H17N3O3SK 406.0622; found
406.0618.
Ethyl-2-(8-cyano-5-(2-methoxyphenyl)-3-oxo-5H-thiazolo[3,2-
a]pyridin-2(3H)-ylidene)acetate (8h): Prepared according to GP-B;
after column chromatography (methylene chloride), an orange powder
1
(0.177 mg, 48% yield) was obtained; mp = 188−190 °C; H NMR
(DMSO-d6, 400 MHz) δ 7.30 (t, 1H, J = 7.9 Hz), 7.10 (dd, 1H, J = 7.6
Hz, J = 1.4 Hz), 7.06 (d, 1H, J = 8.2 Hz), 6.94 (t, 1H, J = 7.4 Hz), 6.73 (s,
1H), 6.17 (dd, 1H, J = 4.3 Hz, J = 1.4 Hz), 6.13 (dd, 1H, J = 9.8 Hz, J =
1.5 Hz), 5.79 (dd, 1H, J = 9.8, 4.5 Hz), 4.28 (q, 2H, J = 7.1 Hz), 3.82 (s,
3H), 1.27 (t, 3H, J = 7.1 Hz); 13C{1H} NMR (DMSO-d6, 100 MHz) δ
165.3, 162.6, 155.8, 147.5, 137.9, 129.3, 126.7, 121.6, 120.7, 116.2,
115.7, 115.2, 111.6, 83.8, 61.4, 55.6, 54.4; FT-IR (neat) νmax (cm−1)
3066, 2996, 2970, 2938, 2838, 2204, 1709, 1688; HRMS (ESI-TOF)
m/z [M + H]+ calcd for C19H16N2O4SH 369.0904; found 369.0911;
[M + Na]+ calcd for C19H16N2O4SNa 391.0723; found 391.0731; [M +
K]+ calcd for C19H16N2O4SK 407.0462; found 407.0471.
Methyl-2-(8-cyano-5-(2-methoxyphenyl)-3-oxo-5H-thiazolo[3,2-
a]pyridin-2(3H)-ylidene)acetate (8d): Prepared according to GP-B;
after column chromatography (methylene chloride), an orange powder
1
(0.134 mg, 38% yield) was obtained; mp = 182−184 °C; H NMR
2-(8-Cyano-3-oxo-5-phenyl-5H-thiazolo[3,2-a]pyridin-2(3H)-
ylidene)acetic Acid (8i): Prepared according to GP-B; after column
chromatography (chloroform/ethanol = 10/1), an orange powder
(DMSO-d6, 400 MHz) δ 7.30 (t, 1H, J = 7.8 Hz), 7.10 (dd, 1H, J = 7.5
Hz, J = 1.0 Hz), 7.06 (d, 1H, J = 8.2 Hz), 6.94 (t, 1H, J = 7.4 Hz), 6.75 (s,
1H), 6.17 (dd, 1H, J = 4.2 Hz, J = 0.9 Hz), 6.14 (dd, 1H, J = 9.9 Hz, J =
1.3 Hz), 5.79 (dd, 1H, J = 9.8, 4.5 Hz), 3.81 (s, 6H); 13C{1H} NMR
(DMSO-d6, 100 MHz) δ 166.7, 163.3, 156.4, 148.3, 138.9, 130.1, 127.4,
127.2, 122.4, 121.5, 116.8, 116.6, 115.5, 112.2, 84.5, 56.2, 55.1, 53.3;
FT-IR (neat) νmax (cm−1) 3064, 2995, 2947, 2837, 2207, 1710, 1689;
HRMS (ESI-TOF) m/z [M + H]+ calcd for C18H14N2O4SH 355.0747;
found 355.0753; [M + Na]+ calcd for C18H14N2O4SNa 377.0566;
found 377.0566; [M + K]+ calcd for C18H14N2O4SK 393.0306; found
393.0315.
1
(0.183 mg, 59% yield) was obtained; mp = 219−221 °C; H NMR
(DMSO-d6, 400 MHz) δ 7.34 (m, 5H), 6.71 (s, 1H), 6.21 (dd, 1H, J =
9.8, 1.2 Hz), 6.02 (d, 1H, J = 3.6 Hz), 5.88 (dd, 1H, J = 9.8, 4.6
Hz).13C{1H} NMR (DMSO-d6, 100 MHz) δ 166.8, 163.3, 148.1,
139.2, 138.0, 128.9, 128.4, 126.7, 123.0, 116.6, 116.2, 116.1, 83.6, 58.0;
FT-IR (neat) νmax (cm−1) 3071, 3004, 2966, 2213, 1713, 1671; HRMS
(ESI-TOF) m/z [M + H]+ calcd for C16H10N2O3SH 311.0485; found
311.0484.
2-(8-Cyano-5-(4-methoxyphenyl)-3-oxo-5H-thiazolo[3,2-a]-
pyridin-2(3H)-ylidene)acetic Acid (8j): Prepared according to GP-B;
after column chromatography (chloroform/ethanol = 10/1), an orange
powder (0.231 mg, 68% yield) was obtained; mp = 204−206 °C; 1H
NMR (DMSO-d6, 400 MHz) δ 13.61 (br s, 1H), 7.27 and 6.92
(AA′XX′, 4H, J = 8.5 Hz), 6.69 (s, 1H), 6.21 (d, 1H, J = 9.8 Hz), 5.95
(d, 1H, J = 4.1 Hz), 5.84 (dd, 1H, J = 9.8, 4.6 Hz), 3.73 (s, 3H); 13C{1H}
NMR (DMSO-d6, 100 MHz) δ 166.9, 163.3, 159.3, 147.8, 137.9, 131.0,
128.5, 122.9, 116.8, 116.3, 116.2, 114.2, 83.6, 57.4, 55.1; FT-IR (neat)
νmax (cm−1) 3049, 3006, 2974, 2883, 2853, 2833, 2216, 1709, 1670;
HRMS (ESI-TOF) m/z [M + H]+ calcd for C17H12N2O4SH 341.0591;
found 341.0592; [M + Na]+ calcd for C17H12N2O4SNa 363.0410;
found 363.0408; [M + K]+ calcd for C17H12N2O4SK 379.0149; found
379.0149.
Methyl (2-(Cyanomethylene)-5-oxothiazolidin-4-ylidene)acetate
(9a): Prepared according to GP-C; white powder (1.428 g, 68% yield);
mp = 223−225 °C; 1H NMR (DMSO-d6, 400 MHz) δ 12.9 (br s, 1H),
6.72 and 6.66* (s, 1H); 5.44* and 5.39 (s, 1H), 3.81 and 3.78* (s, 3H);
5:1 mixture of isomers; 13C{1H} NMR (DMSO-d6, 100 MHz) δ 166.1*
and 166.0, 165.7* and 165.2, 154.8 and 153.5*, 142.6* and 141.8, 116.6
and 115.4*, 114.5 and 113.6*, 72.2 and 70.2*, 52.7 and 52.5*; FT-IR
(neat) νmax (cm−1) 3155, 2965, 2820, 2224, 1730, 1682; MS-EI, m/z
210 (M+, 83%). Anal. Calcd for C8H6N2O3S: C, 45.71; H, 2.88 2.86; N,
13.33. Found: C, 45.69; H, 2.80; N, 13.30.
Ethyl-2-(8-cyano-3-oxo-5-phenyl-5H-thiazolo[3,2-a]pyridin-
2(3H)-ylidene)acetate (8e): Prepared according to GP-B; after column
chromatography (methylene chloride), an orange powder (0.152 mg,
45% yield) was obtained; mp = 191−193 °C; 1H NMR (DMSO-d6, 400
MHz) δ 7.35 (m, 5H), 6.75 (s, 1H), 6.23 (d, 1H, J = 9.8 Hz), 6.03 (d,
1H, J = 4.3 Hz), 5.90 (dd, 1H, J = 9.8, 4.5 Hz), 4.27 (q, 2H, J = 7.0 Hz),
1.26 (t, 3H, J = 7.1 Hz); 13C{1H} NMR (DMSO-d6, 100 MHz) δ 165.5,
163.1, 147.4, 139.1, 138.2, 128.9, 128.4, 126.7, 123.2, 116.4, 115.8,
115.7, 84.2, 61.7, 58.1, 13.9; FT-IR (neat) νmax (cm−1) 3066, 2983,
2962, 2887, 2213, 1707, 1683; HRMS (ESI-TOF) m/z [M + H]+ calcd
for C18H14N2O3SH 339.0798; found 339.0798; [M + Na]+ calcd for
C18H14N2O3SNa 361.0617; found 361.0617; [M + K]+ calcd for
C18H14N2O3SK 377.0357; found 377.0367.
Ethyl-2-(8-cyano-5-(4-methoxyphenyl)-3-oxo-5H-thiazolo[3,2-
a]pyridin-2(3H)-ylidene)acetate (8f): Prepared according to GP-B;
after column chromatography (methylene chloride), an orange powder
1
(0.287 mg, 78% yield) was obtained; mp = 152−154 °C; H NMR
(DMSO-d6, 400 MHz) δ 7.27 and 6.92 (AA′XX′, 4H, J = 8.6 Hz), 6.73
(s, 1H), 6.23 (d, 1H, J = 9.8 Hz), 5.96 (d, 1H, J = 4.4 Hz), 5.86 (dd, 1H,
J = 9.8, 4.6 Hz), 4.26 (q, 2H, J = 7.0 Hz), 3.73 (s, 3H), 1.26 (t, 3H, J =
7.1 Hz); 13C{1H} NMR (DMSO-d6, 100 MHz) δ 165.6, 163.1, 159.3,
147.2, 138.4, 130.9, 128.5, 123.2, 116.2, 116.1, 115.5, 114.2, 84.0, 61.7,
57.5, 55.1, 13.9; FT-IR (neat) νmax (cm−1) 3063, 2992, 2960, 2904,
2838, 2211, 1705, 1683; HRMS (ESI-TOF) m/z [M + H]+ calcd for
C19H18N2O4SH 369.0904; found 369.0905; HRMS (ESI-TOF) m/z
[M + H]+ calcd for C19H16N2O4SH 369.0904; found 369.0905; [M +
Ethyl (2-(Cyanomethylene)-5-oxothiazolidin-4-ylidene)acetate
(9b): Prepared according to GP-C; white powder (1.882 g, 84%
yield); mp = 201−203 °C; 1H NMR (DMSO-d6, 400 MHz) δ 12.9 (br
L
J. Org. Chem. XXXX, XXX, XXX−XXX